Litcius/Paper detail

Anti-PD-1/L1 plus anti-angiogenesis therapy as second-line or later treatment in advanced lung adenocarcinoma

Di Huang, Pengfei Cui, Ziwei Huang, Zhaozhen Wu, Haitao Tao, Sujie Zhang, Rong Xiang, Yi Hu

2020Journal of Cancer Research and Clinical Oncology22 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInternal medicineHazard ratioAdenocarcinomaAngiogenesisOncologyProportional hazards modelSurgeryGastroenterologyConfidence intervalCancerLung Cancer Research StudiesAngiogenesis and VEGF in CancerHepatocellular Carcinoma Treatment and Prognosis
Anti-PD-1/L1 plus anti-angiogenesis therapy as second-line or later treatment in advanced lung adenocarcinoma | Litcius